[Study of skeletal muscle cholinoreceptors using alkylating agents].
The ability of decamethonium containing beta-clorethylamino groups to alkylate the nicotinic cholinoreceptors of the frog tonic muscles was studied. D-tubocurarine prevented the action of the alkylating decamethonium (AD). The latter equally inhibited the effects of carbacholine and tetramethylammonium. The degree of alkylation did not change with pH varying from 6 to 11. AD did not produce any parallel shifts, but inhibited at once the maximal response to carbacholine both of the frog intact muscle and of a single tonic fibre. It is suggested that decamethonium blocks the cholinoreceptors anionic sites, which are represented by the carboxylate, or phosphate anions. The frog tonic muscle probably fails to posses any spare receptors.
D000478:Alkylation; D000818:Animals; D001001:Anura; D008725:Bis-Trimethylammonium Compounds / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D003650:Decamethonium Compounds / Q000378:metabolism* / Q000494:pharmacology; D004347:Drug Interactions; D009132:Muscles / Q000378:metabolism*; D010276:Parasympatholytics; D011950:Receptors, Cholinergic / Q000378:metabolism*; D014403:Tubocurarine / Q000494:pharmacology
D008725:Bis-Trimethylammonium Compounds; D003650:Decamethonium Compounds; D010276:Parasympatholytics; D011950:Receptors, Cholinergic; D002217:Carbachol; D014403:Tubocurarine
Izuchenie kholinoretseptorov skeletnoĭ myshtsy s pomoshch'iu alkiliruiushchikh agentov.